AN2 Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ANTX, updated each market day.
ANTX AI Sentiment
AI sees no strong directional signal for AN2 Therapeutics, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About AN2 Therapeutics, Inc. Common Stock
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Sector
Exchange
Market Cap
$109,620,644
Cap Tier
Employees
21
Headquarters
MENLO PARK, CA
Listed Since
March 25, 2022
Website
ANTX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ANTX Volatility
AN2 Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
